Peter is currently in the final year of his Mitacs Elevate Postdoctoral Fellowship at McMaster University. Supported by his industrial partner, Sentinelle Medical, Inc. (a Hologic company), he is focused on clinical applications of combined MRI and ultrasound for improving diagnosis and treatment of cancer patients.
Over the course of his Accelerate internship Zaifman, a postdoctoral fellow at the Chemistry department of the University of British Columbia, partnered with AlCana, a Vancouver biotechnology company developing lipid nanoparticles, which show great potential as a new means for the targeted delivery of therapeutics.
One of the most talked-about biomedical breakthroughs of 2010, this new development offers hope to sufferers of blood and immunological diseases, such as leukemias, who are often unable to find a suitable donor.
“Ideally, under further development, we hope to be able to grow mature blood cells for patients from their own skin, lessening the likelihood of rejection,” Eva said.